References

1. ElmerGW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996;275:870-876.

2. McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol. 1993;6:251-264.

3. Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. 1992;116:353-357.

4. Friedlander A, Druker MM, Schachter A. Lactobacillus acidophillus and vitamin B complex in the treatment of vaginal infection. Panminerva Med. 1986;28:51-53.

5. Hilton E, Rindos P, Isenberg HD. Lactobacillus GG vaginal supositories and vaginitis [letter]. J Clin Microbiol. 1995;33:1433.

6. Reid G, Bruce AW, McGroarty JA, et al. Is there a role for lactobacilli in prevention of urogenital and intestinal infections. Clin Microbiol Rev. 1990;3:335-344.

7. Williams LR, Home VN, Zhang X, et al. The composition and bactericidal activity of oil of Melaleuca alternifolia (tea tree oil). Int J Aromather. 1989;1:15-17.

8. Hammer KA, Carson CF, Riley TV. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil [letter]. Antimicrob Agents Chemother. 1999;43:196.

9. Pea EF. Melaleuca alternifolia oil. Its use for trichomonal vaginitis and other vaginal infections. Obstet Gynecol. 1962;19:793-795.

10. Lippert U, Walter A, Hausen B, et al. Increasing incidence of contact dermatitis to tea tree oil [abstract]. J Allergy Clin Immunol. 2000;105(1 pt 2):A127.

11. van Slyke KK, Michel VP, Rein MF. Treatment of vulvovaginal candidiasis with boric acid powder. Am J Obstet Gynecol. 1981;141:145-148.

12. Jovanovic R, Congema E, Nguyen HT. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med. 1991;36:593-597.

13. Penna RP, Corrigan LL, Welsh J, et al. Handbook of Nonprescription Drugs. 6th ed. Washington, DC: American Pharmaceutical Association; 1979:424.

14. Giron LM, Aguilar GA, Caceres A, et al. Anticandidal activity of plants used for the treatment of vaginitis in Guatemala and clinical trial of a Solanum nigrescens preparation. J Ethnopharmacol. 1988;22:307-313.

15. Zawadzki J, Suchy H, Scheller S. Use of propolis for treatment of vaginitis and cervicitis [in Polish; English abstract]. Przegl Lek. 1973;30:620-623.

16. Guiraud P, Steiman R, Campos-Takaki GM, et al. Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone. Planta Med. 1994;60:373-374.

17. Sandhu, D.K. Warraich, MK Singh S. Sensitivity of yeast isolated from cases of vaginitis to aqueous extracts of garlic. Mykosen. 1981;23:691-698.

18. Ghannoum MA. Studies on the anticandidal mode of action of Allium sativum (garlic). J Gen Microbiol. 1988;134:2917-2924.

19. Hughes BG, Lawson LD. Antimicrobial effects of Allium sativum L. (garlic), Alliumampeloprasum L. (elephant garlic), and Allium cepa L. (onion), garlic compounds and commercial garlic supplement products. Phytother Res. 1991;5:154-158.

20. Kaneda Y, Torii M, Tanaka T, et al. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica , Giardia lamblia and Trichomonas vaginalis . Ann Trop Med Parasitol. 1991;85:417-425.

21. Pattnaik S, Subramanyam VR, Bapaji M, et al. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios. 1997;89:39-46.

22. Quale JM, Landman D, Zaman MM, et al. In vitro activity of Cinnamomum zeylanicum against azole resistant and sensitive Candida speces and a pilot study of cinnamon for oral candidiasis. Am J Chin Med. 1996;24:103-109.

23. Singh HB, Srivastava M, Singh AB, et al. Cinnamon bark oil, a potent fungitoxicant against fungi causing respiratory tract mycoses. Allergy. 1995;50:995-999.

24. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35:131-134.

25. Jeavons HS. Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus . J Obstet Gynecol Neonatal Nurs. 2003;32:287-296.

26. Pirotta M, Gunn J, Chondros P, et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ. 2004;329:548.

28. Petersen EE, Magnani P. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis; a randomised, double blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2004;117:70-75.

29. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis . Clin Microbiol Infect. 2007;13:657-664.

30. Larsson PG, Stray-Pedersen B, Ryttig KR, et al. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health. 2008 Jan 15.

31. Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review. Clin Ther. 2008;30:453-468.

32. Petricevic L, Witt A. The role of L actobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG. 2008;115:1369-1374.

33. Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol. 2010;203(2):120.e1-6.